Magellan & Macquarie: Why look for the needle when you can buy the haystack?

Should you buy Magellan (ASX:MFG) or Macquarie Group Ltd (ASX:MQG) at today's share prices?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many investors look to the small-cap or 'casino' end of the share market in the hope of finding rocketing shares to create potentially life-changing wealth for themselves and their families.

However, for mum and dad investors this is generally a risky strategy best left to highly-experienced or professional investors, as for every diamond there's plenty of roughies in small-cap land.

So why look for the needle when you can just buy the haystack?

Both Magellan Financial Group Ltd (ASX: MFG) and Macquarie Group Ltd (ASX: MQG) look like haystacks in that they offer investors exposure to a broad range of international equities and infrastructure products, while boasting potential for strong long-term returns.

Check out their returns in 2019 alone.

Magellan at $31.85 is up 37% and about to pay a 73.8 cents per share dividend. It offers a trailing yield of 5.1% plus close to full franking credits.

Macquarie at $126 is up close to 18% and offers a 4.2% trailing yield plus partial franking credits.

Over the past 5 years both these businesses have more than doubled in value, while paying strong dividends along the way.

In other words due to their high quality they're able to leverage rising capital markets to produce ever stronger profit growth, while giving investors some very broad exposure to global markets and a weaker Australian dollar.

One common strength both businesses possess is an ability to recruit and generally retain some of the best staff going due to the high rates of pay and remuneration policies that offer incrementally vesting equity in the businesses.

After all they're both client-facing and human services businesses where being able to attract the right staff counts for an awful lot.

Magellan in particular has a big advantage over fund manger peers such as Perpetual Limited (ASX: PPT) or Pendal Group Ltd (ASX: PDL) in that it's founder led and can retain a tight control on recruitment and staffing.

Its cost-to-income ratio for the six months to December 31 2019 came in at just 17.7% showing how a high-quality fund manager can be run.

Remember, Magellan does not attempt to save on institutional business development (sales) or retail distribution costs either, on the contrary it invests heavily in them.

While Macquarie does not carry any passengers in terms of staffing, which means everyone is pulling their weight via long hours and full workloads to make for a profit-generating machine, despite a much higher cost-to-income ratio that reflects the alignment of staff and shareholders' interests.

Of course staffing is an intangible asset or quality (like a brand) and it's hard to assign a valuation to it, but you only have to look to the track records of profit growth and big share price gains of Magellan and Macquarie to realise the importance of it in some sectors.

As such I'd continue to rate these stocks as decent buys given they can produce strong total returns without the high risk associated with investing at the small cap end of the market.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited and Magellan Financial Group. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »